Ke Xu
About Ke Xu
Ke Xu is the Scientific Associate Director at Bristol Myers Squibb with over 27 years of experience in the pharmaceutical and biosciences industries.
Scientific Associate Director at Bristol Myers Squibb
Ke Xu serves as the Scientific Associate Director at Bristol Myers Squibb, a position held for over 17 years. This role involves significant responsibility in guiding scientific research projects and driving innovative solutions in the pharmaceutical field. Bristol Myers Squibb is globally recognized for its contributions to developing critical therapies, and Ke Xu's long-standing association with the company highlights a deep commitment to advancing medical science.
Previous Role as Principal Scientist at Pfizer
Ke Xu was employed at Pfizer as a Principal Scientist from 1997 to 2006. During the 9-year tenure, Ke Xu contributed to the development and research of new pharmaceutical products. Pfizer, known for its broad portfolio of medicines and vaccines, offered Ke Xu a platform to hone skills and contribute to significant pharmaceutical advancements.
Postdoctoral Experience at Neurocrine Biosciences
Ke Xu began their career in the pharmaceutical industry with a postdoctoral role at Neurocrine Biosciences from 1996 to 1997. This position provided an essential foundation for future roles in pharmaceutical research and development. The experience gained at Neurocrine Biosciences played a crucial role in shaping Ke Xu's professional journey.
Educational Background at Fudan University and Rensselaer
Ke Xu holds an extensive educational background with 10 years of study at Fudan University from 1982 to 1992. Following this, Ke Xu pursued further education at Rensselaer at Work from 1998 to 2000. This combination of rigorous academic training has equipped Ke Xu with the knowledge and skills essential for an impactful career in the pharmaceutical sciences.
Over 27 Years of Experience in Pharmaceutical and Biosciences Industries
Ke Xu has amassed over 27 years of experience in the pharmaceutical and biosciences industries since starting a career in 1996. This extensive period includes roles at prestigious companies such as Pfizer, Neurocrine Biosciences, and Bristol Myers Squibb, reflecting a solid track record in scientific research and pharmaceutical development.